Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury.

Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury.
复制标题

DOI:
10.1002/sctm.17-0065
复制
发表时间:
2017-10
影响因子:
6
通讯作者:
Lebkowski JS
Lebkowski JS
中科院分区:
医学2区
文献类型:
--
作者:
Manley NC;Priest CA;Denham J;Wirth ED 3rd;Lebkowski JS

文献摘要

参考文献

被引文献

相似文献

Cervical spinal cord injury (SCI) remains an important research focus for regenerative medicine given the potential for severe functional deficits and the current lack of treatment options to augment neurological recovery. We recently reported the preclinical safety data of a human embryonic cell‐derived oligodendrocyte progenitor cell (OPC) therapy that supported initiation of a phase I clinical trial for patients with sensorimotor complete thoracic SCI. To support the clinical use of this OPC therapy for cervical injuries, we conducted preclinical efficacy and safety testing of the OPCs in a nude rat model of cervical SCI. Using the automated TreadScan system to track motor behavioral recovery, we found that OPCs significantly improved locomotor performance when administered directly into the cervical spinal cord 1 week after injury, and that this functional improvement was associated with reduced parenchymal cavitation and increased sparing of myelinated axons within the injury site. Based on large scale biodistribution and toxicology studies, we show that OPC migration is limited to the spinal cord and brainstem and did not cause any adverse clinical observations, toxicities, allodynia, or tumors. In combination with previously published efficacy and safety data, the results presented here supported initiation of a phase I/IIa clinical trial in the U.S. for patients with sensorimotor complete cervical SCI. Stem Cells Translational Medicine 2017;6:1917–1929
DOI: 10.1089/neu.2015.3892
发表时间: 2015-11-01
影响因子: 4.2
作者:
Hosier H;Peterson D;Tsymbalyuk O;Keledjian K;Smith BR;Ivanova S;Gerzanich V;Popovich PG;Simard JM
通讯作者: Simard JM
DOI: 10.1371/journal.pone.0116933
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者:
All AH;Gharibani P;Gupta S;Bazley FA;Pashai N;Chou BK;Shah S;Resar LM;Cheng L;Gearhart JD;Kerr CL
通讯作者: Kerr CL
DOI: 10.1016/j.stemcr.2014.06.012
发表时间: 2014-08-12
期刊: STEM CELL REPORTS
影响因子: 5.9
作者:
Douvaras, Panagiotis;Wang, Jing;Zimmer, Matthew;Hanchuk, Stephanie;O'Bara, Melanie A.;Sadiq, Saud;Sim, Fraser J.;Goldman, James;Fossati, Valentina
通讯作者: Fossati, Valentina
DOI: 10.1038/sc.2008.148
发表时间: 2009-04-01
期刊: SPINAL CORD
影响因子: 2.2
作者:
Anderson, K. D.;Friden, J.;Lieber, R. L.
通讯作者: Lieber, R. L.
DOI: 10.1089/neu.2000.17.1205
发表时间: 2000-12-01
影响因子: 4.2
作者:
Hulsebosch, CE;Xu, GY;McAdoo, DJ
通讯作者: McAdoo, DJ